For this Swedish Chambers APAC event, we are delighted to welcome Mr Leon Wang Executive Vice-President, International and President AstraZeneca China. 

We will get the opportunity to hear about AstraZeneca’s efforts to overcome the COVID-19 pandemic, its focus on harnessing the power of science, digital innovation and partnership to build more resilient healthcare systems in a post-pandemic world, and their determination to improve health for as many people in as many countries as possible.

Mr Peter Ling-Vannerus​, Chief Representative, SEB Beijing​, will moderate the conversation with Mr Wang.

When: 14 March, 7.00-8.00 pm AEDT

Platform: This event is hosted by SwedCham China and will be conducted on the platform KUDO, which makes it possible for the audience to switch to Chinese translation. 

Members: Free

Non-Members: $25

Once registered you will receive a link to the online event. 

Leon Wang Executive Vice-President, International and President AstraZeneca China

He is responsible for overall strategy driving sustainable growth across the International region, which includes China. Leon joined AstraZeneca China in March 2013 and was promoted to become President, AstraZeneca China in 2014. Under Leon’s leadership, China has become AstraZeneca’s second largest market worldwide and AstraZeneca has become the largest pharmaceutical company in China. In January 2017, Leon was promoted to Executive Vice-President, Asia Pacific Region. Prior to joining AstraZeneca, Leon held positions of increasing responsibility in marketing and business leadership at Roche, where he was a Business Unit Vice-President. In addition, Leon holds several positions in local trade associations and other prominent organisations in China. Leon holds an EMBA from China Europe International Business School, and a Bachelor of Arts from Shanghai International Studies University.